Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|November 24, 2025
Decay in transcriptional information flow is a hallmark of cellular agingBrooke Emison, Christopher W Lynn, Andrew Mugler, et al.Journal of Vascular and Interventional Radiology : JVIR|April 8, 2015
Endovenous Laser Ablation of Perforating Veins: Feasibility, Safety, and Occlusion Rate Using a 1,470-nm Laser and Bare-Tip FiberMonzer Chehab, Purushottam Dixit, Elias Antypas, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Receptor polarization through localized activity and global sensitizationAndrew Goetz, Purushottam D DixitMolecular Biology and Evolution|April 19, 2021
Reverse Plasticity Underlies Rapid Evolution by Clonal Selection within Populations of Fibroblasts Propagated on a Novel Soft SubstratePurboja Purkayastha, Kavya Pendyala, Ayush S Saxena, et al.Elife|October 29, 2025
Non-equilibrium strategies enabling ligand specificity by signaling receptorsAndrew Goetz, Jeremy Barrios, Ralitsa Radostinova Madsen, et al.Elife|April 20, 2021
The biphasic and age-dependent impact of klotho on hallmarks of aging and skeletal muscle functionZachary Clemens, Sruthi Sivakumar, Abish Pius, et al.Crystal Growth & Design|March 25, 2024
Comparison of N···I and N···O Halogen Bonds in Organoiodine Cocrystals of Heterocyclic Aromatic Diazine Mono-N-oxidesClifford W Padgett, Riley Dean, Audrey Cobb, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignanciesBahram Forouzesh, Chris H Takimoto, Andrew Goetz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Troxacitabine, an L-stereoisomeric nucleoside analog, on a five-times-daily schedule: a phase I and pharmacokinetic study in patients with advanced solid malignanciesJohann S de Bono, Joseph Stephenson, Sharyn D Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignanciesEric K Rowinsky, Jinee Rizzo, Leonel Ochoa, et al.Pageof 3